Vorozole

Vorozole
Systematic (IUPAC) name
6-[(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]- 1-methyl-benzotriazole
Identifiers
CAS number	118949-22-7
ATC code	L02BG05
PubChem	60796
Chemical data
Formula	C16H13ClN6
Mol. mass	324.768 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

WikiDoc Resources for Vorozole
Articles
Most recent articles on Vorozole Most cited articles on Vorozole Review articles on Vorozole Articles on Vorozole in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Vorozole Images of Vorozole Photos of Vorozole Podcasts & MP3s on Vorozole Videos on Vorozole
Evidence Based Medicine
Cochrane Collaboration on Vorozole Bandolier on Vorozole TRIP on Vorozole
Clinical Trials
Ongoing Trials on Vorozole at Clinical Trials.gov Trial results on Vorozole Clinical Trials on Vorozole at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Vorozole NICE Guidance on Vorozole NHS PRODIGY Guidance FDA on Vorozole CDC on Vorozole
Books
Books on Vorozole
News
Vorozole in the news Be alerted to news on Vorozole News trends on Vorozole
Commentary
Blogs on Vorozole
Definitions
Definitions of Vorozole
Patient Resources / Community
Patient resources on Vorozole Discussion groups on Vorozole Patient Handouts on Vorozole Directions to Hospitals Treating Vorozole Risk calculators and risk factors for Vorozole
Healthcare Provider Resources
Symptoms of Vorozole Causes & Risk Factors for Vorozole Diagnostic studies for Vorozole Treatment of Vorozole
Continuing Medical Education (CME)
CME Programs on Vorozole
International
Vorozole en Espanol Vorozole en Francais
Business
Vorozole in the Marketplace Patents on Vorozole
Experimental / Informatics
List of terms related to Vorozole

Vorozole is an aromatase inhibitor used as an antineoplastic agent.